Feedback / Questions
lirentelimab (AK002) - Allakos
http://www.ncbi.nlm.nih.gov/pubmed/34331146
Aug 1, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next